BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lonardo A. Back to the future: From the history of NAFLD to MAFLD to heterogeneity of disease. Clinical and Translational Dis 2021;1. [DOI: 10.1002/ctd2.9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Shea S, Lionis C, Atkinson L, Kite C, Lagojda L, Chaggar SS, Kyrou I, Randeva HS. Support Needs and Coping Strategies in Non-Alcoholic Fatty Liver Disease (NAFLD): A Multidisciplinary Approach to Potential Unmet Challenges beyond Pharmacological Treatment. Livers 2022;3:1-20. [DOI: 10.3390/livers3010001] [Reference Citation Analysis]
2 Quintás G, Caiment F, Rienda I, Pérez-rojas J, Pareja E, Castell JV, Jover R. Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat. IJMS 2022;23:9298. [DOI: 10.3390/ijms23169298] [Reference Citation Analysis]